Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02131311 · ClinicalTrials.gov registry record · NA
A Clinical Study of the Effectiveness and Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence (SUI)
A NA study of Stress Urinary Incontinence (SUI), sponsored by Procter and Gamble.
- Completed
- Registry status
- NA
- Development phase
- 145
- Enrollment target
- 1
- Study location
NCT02131311: Completed NA study of Stress Urinary Incontinence (SUI), sponsored by Procter and Gamble.
NCT02131311 is a NA study of Stress Urinary Incontinence (SUI) that has completed, run by Procter and Gamble. The registered enrollment target is 145 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02131311, a NA study of Stress Urinary Incontinence (SUI), has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- NA
- Development phase
- 145 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the effectiveness of the pessary device by assessing reduction in urine leakage in approximately 80 women with SUI. Efficacy will be assessed by pad weight gain, frequency of stress urinary incontinence events, and a quality of life questionnaire.
Conditions Studied
Interventions
- DEVICE disposable, single-use pessary
Study Locations (1)
Arizona
- Study Center - Chandler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2014-04 |
| Est. Completion | 2014-09 |
| Phase | NA |
What the finished NCT02131311 record still lists
NCT02131311 is an interventional study that assigns participants to a tested intervention. The registered 145 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Stress Urinary Incontinence (SUI) appearing as the primary indexed condition, and to 1 intervention - of which disposable, single-use pessary is the first listed.
NCT02131311 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT02131311 about?
NCT02131311 is a clinical study titled "A Clinical Study of the Effectiveness and Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence (SUI)". This study will evaluate the effectiveness of the pessary device by assessing reduction in urine leakage in approximately 80 women with SUI. Efficacy will be assessed by pad weight gain, frequency of stress urinary incontinence events, and a quality of life questionnaire.
What is the current status of trial NCT02131311?
This trial is currently completed. It is a NA study. The enrollment target is 145 participants. The study started on 2014-04. Estimated completion is 2014-09.
What conditions does trial NCT02131311 study?
This clinical trial studies the following conditions: Stress Urinary Incontinence (SUI).
What interventions are being tested in trial NCT02131311?
The interventions under investigation include: disposable, single-use pessary (DEVICE).
Who is sponsoring clinical trial NCT02131311?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02131311 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress Urinary Incontinence (SUI)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02131311's enrollment target sits among peer trials
145 705th of 2000 higher than 1,295 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02688959 · 145 participants · NA
Motor Attention Training for Attention Deficit Hyperactivity Disorder (ADHD)
- NCT03586609 · 145 participants · Phase 2
Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
- NCT03767595 · 145 participants · NA
ProACT Post-Approval Study
- NCT03808337 · 145 participants · Phase 2
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia